ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Statement Defining Cancer Control Goals, Approaches Okayed By Board

February 6, 1981

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

November 26, 1999

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

NCI Says. President Bush Visits NIH, Marks Decline In U.S. Cancer Deaths For Second Year.

January 19, 2007

Pain Relievers Protect Against Breast Cancer

April 25, 2003

NCI Plans $38 Million For New Research In Tobacco Control Over Next Two Years

October 16, 1998